Lexicon Pharmaceuticals

$1.54
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.08 (+5.45%) As of 10:42 AM EST today

Why Robinhood?

You can buy or sell LXRX and other stocks, options, and ETFs commission-free!

About LXRX

Lexicon Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. Its drug candidates include XERMELO, Zynquista, and LX9211. The company was founded by Brian P. Zambrowicz and Arthur T. Sands on July 7, 1995 and is headquartered in The Woodlands, TX. The listed name for LXRX is Lexicon Pharmaceuticals, Inc. Common Stock.

CEO

Lonnel Coats

Employees

184

Headquarters

The Woodlands, Texas

Founded

1995

Market Cap

179.74M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

13.05M

High Today

$1.54

Low Today

$1.44

Open Price

$1.48

Volume

621.20K

52 Week High

$5.33

52 Week Low

$1.03

Collections

LXRX Earnings

-$0.77

-$0.27

$0.23

$0.73

Q1 FY19

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 11, Pre-Market